Search
引用資料與參考文獻 (10)
Thermo Scientific™
Samco™ Narrow Stem Transfer Pipettes
Ideal for work with narrow tubes and containers with small openings.
Have Questions?
變更視圖
| 產品號碼 | Volume (Metric) | Sterility | Bulb Draw (Metric) | Packaging Type | Unit Size |
|---|---|---|---|---|---|
| 252 | 15.3 mL | Non-sterile | 11.6 mL | Bulk | Case of 2500 |
| 241 | 1.3 mL | Non-sterile | 0.8 mL | Bulk | Case of 4000 |
| 241PK 亦稱為 241 | 1.3 mL | Non-sterile | 0.8 mL | Bulk | Pack of 500 |
| 241-20S | 1.3 mL | Sterile | 0.8 mL | 20/Bag, 500/Pk., 4000/Cs. | Case of 4000 |
| 242NL-1S | 4 mL | Sterile | 3 mL | Individually Wrapped | Case of 8 |
| 694NL | 6.7 mL | Non-sterile | 3.0 mL | 500/Pk. | Each |
| 241NL | 1.2 mL | Non-sterile | 0.8 mL | 500/Pk. | Each |
| 241NL-1S | 1.2 mL | Sterile | 0.8 mL | Individually Wrapped | Each |
| 242NL | 4.0 mL | Non-sterile | 3.0 mL | 500/Pk. | Each |
| 242NL-20S | 4.0 mL | Sterile | 3.0 mL | 20/Bag | Each |
| 251NL | 4.6 mL | Non-sterile | 3.3 mL | 500/Pk. | Each |
| 252NL | 15 mL | Non-sterile | 11.6 mL | 500/Pk. | Each |
| 252NL-20S | 15 mL | Sterile | 11.6 mL | 20/Bag | Each |
| 242 | 4.3 mL | Non-sterile | 3.1 mL | Bulk | Case of 5000 |
| 242PK 亦稱為 242 | 4.3 mL | Non-sterile | 3.1 mL | Bulk | Pack of 500 |
| 242-1S | 4.3 mL | Sterile | 3.1 mL | Individually Wrapped | Case of 4000 |
| 242-1SPK 亦稱為 242-1S | 4.3 mL | Sterile | 3.1 mL | Individually Wrapped | Pack of 500 |
| 242-20S | 4.3 mL | Sterile | 3.1 mL | 20/Bag, 760/Pk., 6080/Cs. | Case of 6080 |
| 251 | 4.5 mL | Non-sterile | 3.3 mL | Bulk | Case of 5000 |
| 251PK 亦稱為 251 | 4.5 mL | Non-sterile | 3.3 mL | Bulk | Pack of 500 |
| 251-1S | 4.5 mL | Sterile | 3.3 mL | Individually Wrapped | Case of 4000 |
| 251-1SPK 亦稱為 251-1S | 4.5 mL | Sterile | 3.3 mL | Individually Wrapped | Pack of 500 |
| 251-20S | 4.5 mL | Sterile | 3.3 mL | 20/Bag, 500/Pk., 4000/Cs. | Case of 500 |
| 252PK 亦稱為 252 | 15.3 mL | Non-sterile | 11.6 mL | Bulk | Pack of 250 |
| 252-1S | 15.3 mL | Sterile | 11.6 mL | Individually Wrapped | Case of 2000 |
| 252-1SPK 亦稱為 252-1S | 15.3 mL | Sterile | 11.6 mL | Individually Wrapped | Pack of 250 |
| 252-20S | 15.3 mL | Sterile | 11.6 mL | 20/Bag, 200/Pk., 2000/Cs. | Case of 1600 |
| 694TS 亦稱為 694 | 6.9 mL | Non-sterile | 3.2 mL | Bulk | Case of 5000 |
| 694TSPK 亦稱為 694 | 6.9 mL | Non-sterile | 3.2 mL | Bulk | Pack of 500 |
| 694-1S | 6.9 mL | Sterile | 3.2 mL | Individually Wrapped | Each |
| 241-1S | 1.3 mL | Sterile | 0.8 mL | Individually Wrapped | Case of 4000 |
產品號碼 252
價格 (HKD)
3,080.00
Case of 2500
Volume (Metric):
15.3 mL
Sterility:
Non-sterile
Bulb Draw (Metric):
11.6 mL
Packaging Type:
Bulk
Unit Size:
Case of 2500
價格 (HKD)
3,080.00
Case of 2500
Eliminate plugging, packaging and autoclaving with Thermo Scientific™ Samco™ Narrow Stem Transfer Pipettes. These polyethylene pipettes prevent cross-contamination and are used narrow tubes and containers with small openings . The single-unit design features a built-in pipette bulb, and a flexible stem bends to sample from narrow or small tubes.
- Made of shatterproof, nontoxic polyethylene
- Low-affinity surface prevents proteins binding in research applications
- Can be frozen in liquid nitrogen, or heat sealed for storage
規格
Bulb Draw (Metric)11.6 mL
DescriptionSedi-Pet Transfer Pipette, Narrow Stem, Large Bulb, 15.3mL
Diameter (Metric) Outer3.0 mm
Drops/mL19
GraduatedNo
Packaging TypeBulk
QuantityBulk 250/Pk 10Pk/Cs 2500/Cs
DisposableSingle-use
Length (Metric)15.5 cm
MaterialLDPE
SterilityNon-sterile
TypeNarrow Stem Transfer Pipet
Volume (Metric)15.3 mL
Unit SizeCase of 2500
引用資料與參考文獻 (10)
引用資料與參考文獻
Abstract
Characterization of the SIM-A9 cell line as a model of activated microglia in the context of neuropathic pain.
Journal:PLoS One
PubMed ID:32287325
'Resident microglia of the central nervous system are being increasingly recognized as key players in diseases such as neuropathic pain. Biochemical and behavioral studies in neuropathic pain rodent models have documented compelling evidence of the critical role of ATP mediated-P2X4R-brain-derived neurotrophic factor (BDNF) signaling pathway in the initiation and maintenance
Expression of the neonatal Fc-receptor in placental-fetal endothelium and in cells of the placental immune system.
Journal:Placenta
PubMed ID:30955709
'Starting from the second trimester of pregnancy, passive immunity is provided to the human fetus by transplacental transfer of maternal IgG. IgG transfer depends on the neonatal Fc receptor, FcRn. While FcRn localization in the placental syncytiotrophoblast (STB) has been demonstrated unequivocally, FcRn expression in placental-fetal endothelial cells (pFECs), which
Sleep-restriction Inhibits Neurogenesis Through Decreasing the Infiltration of CD169
Journal:Neuroscience
PubMed ID:32081723
'Chronic sleep-restriction (SR) is shown to be correlated with neurodevelopmental disorders. However, the effects of SR during stroke recovery on neurorepair remain unclear. In this study, mice were subjected to 60?min of cerebral ischemia followed by reperfusion. The SR protocol was accomplished by depriving mice of sleep for 20?h/day for
CRISPR Interference-Based Platform for Multimodal Genetic Screens in Human iPSC-Derived Neurons.
Journal:Neuron
PubMed ID:31422865
CRISPR/Cas9-based functional genomics have transformed our ability to elucidate mammalian cell biology. However, most previous CRISPR-based screens were conducted in cancer cell lines rather than healthy, differentiated cells. Here, we describe a CRISPR interference (CRISPRi)-based platform for genetic screens in human neurons derived from induced pluripotent stem cells (iPSCs). We
The WNT/ß-catenin signaling inhibitor XAV939 enhances the elimination of LNCaP and PC-3 prostate cancer cells by prostate cancer patient lymphocytes in vitro.
Journal:Sci Rep
PubMed ID:30886380
Upregulated Wnt/ß-catenin signaling is associated with increased cancer cell resistance and cancer cell-elicited immunosuppression. In non-neoplastic immune cells, upregulated Wnt/ß-catenin is, however, associated with either immunosuppression or immunostimulation. Therefore, it is difficult to predict the therapeutic impact inhibitors of Wnt/ß-catenin signaling will have when combined with cancer immunotherapy. Here, we